Sanofi SA (SNY)
46.68
-1.00
(-2.10%)
USD |
NASDAQ |
Apr 24, 16:00
46.68
0.00 (0.00%)
After-Hours: 20:00
Sanofi Price: 46.68 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 47.07 | 48.38 | 47.00 | 47.68 | 1.625M |
| Apr 22, 2024 | 46.14 | 47.16 | 46.12 | 47.15 | 2.086M |
| Apr 19, 2024 | 45.89 | 46.73 | 45.79 | 46.30 | 3.272M |
| Apr 18, 2024 | 45.47 | 45.71 | 45.22 | 45.39 | 4.360M |
| Apr 17, 2024 | 46.33 | 46.42 | 45.88 | 46.11 | 3.715M |
| Apr 16, 2024 | 46.03 | 46.27 | 45.80 | 45.80 | 1.357M |
| Apr 15, 2024 | 46.76 | 46.90 | 46.01 | 46.24 | 1.997M |
| Apr 12, 2024 | 45.98 | 46.16 | 45.83 | 45.93 | 1.694M |
| Apr 11, 2024 | 47.40 | 47.45 | 46.29 | 46.60 | 1.218M |
| Apr 10, 2024 | 47.38 | 47.45 | 46.96 | 47.13 | 2.947M |
| Apr 09, 2024 | 47.14 | 47.59 | 47.07 | 47.53 | 3.325M |
| Apr 08, 2024 | 47.33 | 47.39 | 47.10 | 47.15 | 1.511M |
| Apr 05, 2024 | 46.94 | 47.38 | 46.89 | 47.25 | 1.290M |
| Apr 04, 2024 | 48.67 | 48.67 | 47.80 | 47.80 | 1.758M |
| Apr 03, 2024 | 48.00 | 48.25 | 47.78 | 47.96 | 1.363M |
| Apr 02, 2024 | 48.21 | 48.22 | 47.68 | 47.70 | 1.306M |
| Apr 01, 2024 | 49.07 | 49.07 | 48.01 | 48.29 | 1.298M |
| Mar 28, 2024 | 49.25 | 49.44 | 48.30 | 48.60 | 2.415M |
| Mar 27, 2024 | 49.67 | 49.85 | 49.53 | 49.54 | 2.530M |
| Mar 26, 2024 | 49.19 | 49.83 | 49.16 | 49.75 | 3.615M |
| Mar 25, 2024 | 48.23 | 50.50 | 48.20 | 49.44 | 3.650M |
| Mar 22, 2024 | 48.16 | 48.27 | 47.84 | 48.07 | 2.333M |
| Mar 21, 2024 | 47.40 | 47.82 | 47.38 | 47.73 | 1.581M |
| Mar 20, 2024 | 47.33 | 48.30 | 47.24 | 48.23 | 990492.0 |
| Mar 19, 2024 | 47.32 | 47.54 | 47.23 | 47.48 | 633700.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.22
Minimum
Sep 27 2022
57.46
Maximum
Apr 11 2022
48.89
Average
49.49
Median
Jun 01 2020
Price Benchmarks
| AstraZeneca PLC | 71.17 |
| GSK PLC | 40.86 |
| Novo Nordisk A/S | 126.20 |
| Regeneron Pharmaceuticals Inc | 906.80 |
| Inhibrx Inc | 34.41 |
Price Related Metrics
| PE Ratio | 19.92 |
| PS Ratio | 2.324 |
| Price to Book Value | 1.424 |
| Earnings Yield | 5.02% |
| Market Cap | 116.57B |
| Operating PE Ratio | 10.38 |
| Normalized PE Ratio | 14.70 |